See also this year's filing and all EDGAR filings for this company.
PDF Report 0001680581_2023_Fulcrum_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001680581, Fulcrum Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 207,519,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,906,000 |
| 3 | remainder_Assets | 12,260,000 |
| 4 | LiabilitiesCurrent | 16,725,000 |
| 5 | LiabilitiesNoncurrent | 11,018,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 80,584,401 |
| 9 | ResearchAndDevelopmentExpense | 75,748,014 |
| 10 | remainder_Expenses | 427,000 |
| 11 | remainder_Revenues | 8,694,823 |
| 12 | remainder_NetIncome | 1,550,858 |
| 13 | remainder_ComprehensiveNetIncome | -400,090 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 226,685,000 |
| 1 | Liabilities | 27,743,000 |
| 2 | Expenses | 156,759,415 |
| 3 | Revenues | 8,694,823 |
| 4 | StockholdersEquity | 198,942,000 |
| 5 | NetIncome | -146,513,734 |
| 6 | ComprehensiveNetIncome | -146,713,779 |
| 7 | BaseVar | 210,916,593 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.26 |
| 9 | EconomicCapitalRatio | 3.19 |
Edgar->Model Mapping
Feature Distribution
Change over Time
